| |
N
|
LET+ NAAT+
|
LET- NAAT+
|
LET+ NAAT-
|
LET- NAAT-
|
Sens. (95 % CI)
|
Spec. (95 % CI)
|
PPV (95 % CI)
|
NPV (95 % CI)
|
Agr.
|
Kappa
|
|---|
|
LET 2 m
|
|
ALL
|
645
|
68
|
20
|
233
|
324
|
77.3 % (67.1–85.5)
|
58.1 % (53.9–62.3)
|
22.6 % (18.0–27.7)
|
94.2 % (91.1–96.4)
|
60.8 %
|
0.176
|
|
Sympto-matic patients
|
257
|
44
|
9
|
100
|
104
|
83.0 % (70.2–91.9)
|
51.0 % (43.9–58.0)
|
30.6 % (23.2–38.8)
|
92.0 % (85.4–96.3)
|
57.6 %
|
0.208
|
|
Asympto-matic patients
|
379
|
23
|
11
|
129
|
216
|
67.6 % (49.5–82.6)
|
62.6 % (57.2–67.7)
|
15.1 % (9.8–21.8)
|
95.1 % (91.4–97.5)
|
63.1 %
|
0.026
|
|
<25 years
|
110
|
18
|
3
|
41
|
48
|
85.7 % (63.7–97.0)
|
53.9 % (43.0–64.6)
|
30.5 % (19.2–43.9)
|
94.1 % (84.8–98.8)
|
60.0 %
|
0.068
|
|
LET 5 m
|
|
ALL
|
645
|
80
|
8
|
330
|
227
|
90.9 % (82.9–96.0)
|
40.8 % (36.7–45.0)
|
19.6 % (15.9–23.8)
|
96.6 % (93.4–98.5)
|
47.6 %
|
0.125
|
- *Sensitivity (Sens.), Specificity (Spec.), Positive Predictive Value (PPV), Negative Predictive Value (NPV), Agreement (Agr.) and Kappa
